Dr. Wm David Hardy (he/him) serves as Clinical Professor of Family Medicine, Keck School of Medicine, University of Southern California (USC) and teaches trainees in the LA County-USC Rand Schrader HIV Clinic. He provides HIV consultation for the USC Street Medicine Program. His recent past appointments/positions include:
1) Co-Principal Investigator, Coronavirus Prevention Network (CoVPN), CTRC, Charles Drew University of Medicine and Science (2019-2022)
2) Senior Director of Research, Whitman-Walker Health overseeing NIH-funded ACTG clinical trials/cure studies, HIV Cohort studies and industry-sponsored trials (2015-18)
3) Adjunct Professor of Medicine, Johns Hopkins University School of Medicine (2015-19)
4) Director, Division of Infectious Diseases, Cedars-Sinai Medical Center (2002-13)
5) Professor of Medicine, David Geffen School of Medicine, UCLA (2002-2013)
6) Chief Medical Officer, Calimmune, Inc, start-up biotechnology company, funded by CIRM, using gene-modified CD4+ T cells and hematopoietic stem cells as potential cure for HIV infection (2013-2015)
7) Acting Chief Medical Officer/Consultant, Enochian BioSciences, biotechnology start-up company developing cell and gene-based cures for life-threatening viral infections and cancers (2018-2022)
He received his medical degree from Baylor College of Medicine and completed his residency in internal medicine at Harbor-UCLA Medical Center. Early in the AIDS epidemic, he completed a clinical fellowship in infectious diseases/immunology and clinical research at the UCLA School of Medicine under the direction of Dr. Michael Gottlieb, the physician who recognized and reported the first cases of AIDS. He also completed a laboratory fellowship in molecular retrovirology with Irvin Chen, PhD at the David Geffen School of Medicine at UCLA focusing on development of retroviral vector delivery of gene therapy and vaccine applications.
Dr. Hardy has cared for persons with HIV since 1982 and conducted research on HIV and related diseases since 1984. His research has focused on treatment and prevention of opportunistic infections, antiretroviral therapy, immunotherapies, hepatitis treatments, retroviral vector research, cellular and gene therapy. Dr Hardy served as Chair of the Board of Directors of the HIV Medicine Association (HIVMA) 2018-2019. Currently, he serves as Treasurer for the American Academy of HIV Medicine (AAHIVM). He served as editor-in-chief of AAHIVM’s comprehensive clinical textbook, Fundamentals of HIV Medicine for the HIV Specialist published in 2007, ‘08, ‘12, ‘17, ‘19, ‘21 and ‘23. He has volunteered with several Los Angeles community-based organizations, including AIDS Research Alliance, the Alliance for Housing and Healing, Being Alive-Empowering People with HIV/AIDS, Project Angel Food, AIDS Project-Los Angeles and the Foundation for the AIDS Monument.
